Susan Hasty, Publisher
Table of Contents . . . September 19th, 2000
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Cancer Weekly | Other Publications
Head and Neck Cancers - Radiotherapy Technique Spares Glands in Oropharynx and Larynx, Increases Dose Homogeneity
Abdominal Cancer - Suramin Toxicity Reduced by Alternative Mode Delivery
Anaplastic Thyroid Carcinoma - Newly-Discovered Drug Prolongs Survival in Some Patients with Rare Cancer
Ethical Issues - Study: Terminally Ill Cancer Patients Favor Legalization of Euthanasia and Physician-Assisted Suicide
Imaging Technology - Researchers Say "Hawkeye" Scanner Big Stride in Cancer Fight
Leukemia - Method Developed to Identify Patients at High Risk for Relapse
Oral Cancers - Measuring Telomerase Activity May Have Prognostic and Diagnostic Applications
Lung Cancer - Lung-Sparing Technique Improves Quality of Life without Sacrificing Cure
Micrometastatic Cancer - FDA Clears Applied Imaging System to Detect Cancer Cells
Adverse Drug Effects - Long-Term Tamoxifen Users Have Worse Prognosis of Endometrial Cancers
Blood Purging - Magnetic Bead Immunoselection Process Removes Ewing's Sarcoma Cells
Brain Cancer - Adenovirus is Aggressive Against Tumor Xenografts
Cancer Therapies - Cyanide Shows Promise in Treatment
Cancer Therapies - Fungal Metabolite Cytochalasin E Exhibits Anti-Tumor Properties in Mouse Model
Cancer Vaccines - Mycobacterium tuberculosis Ag38 Gene Cooperates with Interleukin 12 Against Tumors
Glioma - Results of p53 Gene Therapy Trial in Recurrent Cancer are Encouraging
Leptomeningeal Cancer - Radioimmunotherapy with 131-I-3F8 Monoclonal Antibody Reaches Phase I Trial
Ovarian Cancer - Adoptive Immunotherapy Reported Safe and Feasible
Prostate Cancer - Phase I Trial Targets Monoclonal Antibody to Prostate-Specific Membrane Antigen
Shiga B Protein - Bacterial Protein Shows Promise for Cancer Vaccine
Squamous Cell Carcinoma - Antisense Vascular Endothelial Growth Factor Therapy is Promising
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.